This article is freely available to all

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

Clinicians currently have a large number of pharmaceutical options available for the treatment of depression, yet not one of these treatments is associated with especially high remission rates. Further complicating the treatment of depression is the fact that the more failed treatment trials a patient undergoes, the lower the odds that remission will be achieved. Therefore, choosing the drug that will be most effective for a particular patient early in the treatment process is essential. Antidepressant treatment algorithms are helpful in this regard.